Výsledky vyhledávání - "James V, Fiorica"

Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study

Autor: Russell J, Schilder, William E, Brady, Heather A, Lankes, James V, Fiorica, Mark S, Shahin, Xun C, Zhou, Robert S, Mannel, Harsh B, Pathak, Wei, Hu, R Katherine, Alpaugh, Anil K, Sood, Andrew K, Godwin

Publikováno v: Gynecologic Oncology. 127:70-74

Preclinical data suggest an important role for the sarcoma proto-oncogene tyrosine kinase (SRC) in the oncogenesis of epithelial ovarian cancer (EOC) or primary peritoneal carcinoma (PPC). The Gynecologic Oncology Group (GOG) conducted a Phase II tri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1edce07d9adadf2af8b6ac97f10784a6
https://doi.org/10.1016/j.ygyno.2012.06.009

Zobrazit plný text záznamu

Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group study

Autor: James V. Fiorica, Lisa M. Adler, Ira R. Horowitz, P. DiSilvestro, Kathleen M. Darcy, Michael W. Sill, Jonathan S. Berek, Gini F. Fleming, J. Tate Thigpen, Julia Chapman, D. Scott McMeekin

Publikováno v: Gynecologic Oncology. 116:15-20

This study evaluated efficacy of single-agent trastuzumab against advanced or recurrent HER2-positive endometrial carcinoma (EC), and explored predictors for HER2 amplification.Eligible patients had measurable stage III, IV, or recurrent EC. There wa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e46f4f6fbc9b09fc1e22265cbb97ba6
https://doi.org/10.1016/j.ygyno.2009.09.025

Zobrazit plný text záznamu

Micrometastasis of Breast Cancer to the Endometrium, Cervix, and Contralateral Axilla

Autor: James V. Fiorica, Christine C. Tebes, Stephen J. Tebes

Publikováno v: Journal of Gynecologic Surgery. 22:31-34

Background: Common sites of detected metastatic breast cancer include bone, lung, pleura, soft tissues, and liver. However, multiple other areas such as genitourinary, cardiovascular and endocrine can be involved. Case: We present a woman with a fami

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2b8c5f3fa5d21f460c5d97ee59e2768b
https://doi.org/10.1089/gyn.2006.22.31

Zobrazit plný text záznamu

Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study

Autor: Lynne A. Eaton, Helen Q. Huang, Joel I. Sorosky, Bradley J. Monk, David Miller, Harry J. Long, James V. Fiorica, D. Scott McMeekin, Edward C. Grendys

Publikováno v: Gynecologic Oncology. 100:537-543

Objectives. The Gynecologic Oncology Group (GOG) compared methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) with topotecan and cisplatin (TC) or cisplatin alone (C) in advanced cervical cancer. The primary endpoint was overall survival (OS

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f65508c058db1340759e82e94768c63
https://doi.org/10.1016/j.ygyno.2005.09.023

Zobrazit plný text záznamu

In vitro chemoresponse in metachronous pairs of ovarian cancers

Autor: Heather J, Dalton, James V, Fiorica, Robert P, Edwards, Ivor, Benjamin, Rodney P, Rocconi, Fernando O, Recio, John L, Lovecchio, Matthew O, Burrell, Mark S, Shahin, Edward C, Grendys, Dakun, Wang, Tianhua, Wang, Bradley J, Monk

Publikováno v: Anticancer research. 34(12)

An in vitro chemoresponse assay may aid effective therapy selection in epithelial ovarian cancer (EOC). This study explores changes in chemoresponse between paired primary and recurrent EOC tumors.RESULTS from metachronous tumors were examined in 242

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b1e43e8c35da9eccb2b8cac4e216455c
https://pubmed.ncbi.nlm.nih.gov/25503148

Zobrazit plný text záznamu

Upper vaginectomy for the treatment of vaginal intraepithelial neoplasia

Autor: Mitchel S. Hoffman, Martin A. Martino, Megan D. Indermaur, James V. Fiorica, William S. Roberts

Publikováno v: American Journal of Obstetrics and Gynecology. 193:577-581

To evaluate the outcomes of patients with vaginal intraepithelial neoplasia (VAIN) who were treated by upper vaginectomy, the medical records at the University of Florida between August 1985 and April 2004 were reviewed. One hundred five patients wit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d1d999cb95bb08c648c802f0dc9372a
https://doi.org/10.1016/j.ajog.2005.03.055

Zobrazit plný text záznamu

Randomized Phase III Trial of Cisplatin With or Without Topotecan in Carcinoma of the Uterine Cervix: A Gynecologic Oncology Group Study

Autor: Lynne A. Eaton, Harry J. Long, Joel I. Sorosky, James V. Fiorica, David Miller, Jo Ann Benda, D. Scott McMeekin, Edward C. Grendys, Brian N. Bundy

Publikováno v: Journal of Clinical Oncology. 23:4626-4633

Purpose On the basis of reported activity of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) or topotecan plus cisplatin in advanced cervix cancer, we undertook a randomized trial comparing these combinations versus cisplatin alone, to d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::904990f925d8f3db203dccc4d5508393
https://doi.org/10.1200/jco.2005.10.021

Zobrazit plný text záznamu

Accuracy of pelvic examination in the assessment of patients with operable cervical cancer

Autor: Richard J. Cardosi, William S. Roberts, James V. Fiorica, Mitchel S. Hoffman, David Griffin, Edward C. Grendys

Publikováno v: American Journal of Obstetrics and Gynecology. 190:986-992

The purpose of this study was to determine whether pelvic examination identifies factors that suggest the need for radiotherapy after radical hysterectomy for cervical cancer.This was an observational study that was conducted from July 1, 2000 throug

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a64f9ce0bc6de6bf47c062036511b0b
https://doi.org/10.1016/j.ajog.2004.01.019

Zobrazit plný text záznamu

Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma: a Gynecologic Oncology Group study

Autor: Parviz Hanjani, Samuel S. Lentz, Virginia L. Brunetto, Robert S. Mannel, Willie A. Andersen, James V. Fiorica

Publikováno v: Gynecologic Oncology. 92:10-14

Objectives . To estimate the objective response rate and toxicity associated with alternating megestrol acetate (MA) and tamoxifen citrate (T) in women with endometrial carcinoma. Methods . Consenting patients with measurable recurrent or advanced en

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e892239696879c60976b206a9fe35ed3
https://doi.org/10.1016/j.ygyno.2003.11.008

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání